UNLOCKING LEGALITIES: Challenges And Surprises In The EU Medtech Reg Reform
This article was originally published in SRA
Executive Summary
The texts of the new EU medical device and IVD regulations have now been published in their likely final versions, save for the tweaking expected during the European Commission's legal review. Scrip Regulatory Affairs sister publication Clinica asked Erik Vollebregt, partner at Axon Lawyers, what the most significant challenges will be now for the whole of the medtech sector, and where the biggest surprises lie.
You may also be interested in...
EU TTIP Device Proposals Rely Heavily on Device Regulators Forum
The European Commission circulated its device-regulation proposals as part of negotiations for the Transatlantic Trade and Investment Partnership with the US. It emphasized convergence of technical and clinical requirements and the important role of the International Medical Device Regulators Forum.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.